AD-associated CSF biomolecular changes are attenuated in KL-VS heterozygotes.
Alzheimers Dement (Amst)
; 14(1): e12383, 2022.
Article
de En
| MEDLINE
| ID: mdl-36505396
ABSTRACT
Introduction:
Dementia as an inevitable aging consequence has been challenged and underscores the need for investigations of the factors that confer resilience. We examine whether the functionally advantageous KL-VS variant of the putative aging suppressor KLOTHO gene attenuates age-related cognitive decline and deleterious biomolecular changes.Methods:
Trajectories of change in memory and executive function (N = 360; 2-12 visits) and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers-amyloid beta (Aß)42, total tau (t-tau), phosphorylated tau (p-tau) (N = 112; 2-4 samplings)-were compared between KL-VS non-carriers and heterozygotes in middle-aged and older adults from the Wisconsin Registry for Alzheimer's Prevention and the Wisconsin Alzheimer's Disease Research Center studies.Results:
Memory and executive function declined (p's ≤ 0.001) and CSF t-tau, p-tau, t-tau/Aß42, and p-tau/Aß42 levels increased (all p's ≤ 0.004) with age. The rate of p-tau accumulation was attenuated for KL-VS heterozygotes (p = 0.03).Discussion:
KL-VS heterozygosity may confer resilience to AD-associated biomolecular changes.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Risk_factors_studies
Langue:
En
Journal:
Alzheimers Dement (Amst)
Année:
2022
Type de document:
Article